Cargando…

Visceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteases

Proteases, enzymes catalyzing the hydrolysis of peptide bonds, are present at high concentrations in the gastrointestinal tract. Besides their well-known role in the digestive process, they also function as signaling molecules through the activation of protease-activated receptors (PARs). Based on t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceuleers, Hannah, Van Spaendonk, Hanne, Hanning, Nikita, Heirbaut, Jelena, Lambeir, Anne-Marie, Joossens, Jurgen, Augustyns, Koen, De Man, Joris G, De Meester, Ingrid, De Winter, Benedicte Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175241/ https://www.ncbi.nlm.nih.gov/pubmed/28058009 http://dx.doi.org/10.3748/wjg.v22.i47.10275

Ejemplares similares

Regulation of intestinal permeability: The role of proteases
por: Van Spaendonk, Hanne, et al.
Publicado: (2017)

Local Colonic Administration of a Serine Protease Inhibitor Improves Post-Inflammatory Visceral Hypersensitivity in Rats
por: Hanning, Nikita, et al.
Publicado: (2021)

The Effect of a Novel Serine Protease Inhibitor on Inflammation and Intestinal Permeability in a Murine Colitis Transfer Model
por: Van Spaendonk, Hanne, et al.
Publicado: (2021)

The Effect of Serine Protease Inhibitors on Visceral Pain in Different Rodent Models With an Intestinal Insult
por: Ceuleers, Hannah, et al.
Publicado: (2022)

Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review
por: Hanning, Nikita, et al.
Publicado: (2021)

Volatile organic compound profiling as a potential biomarker in irritable bowel syndrome: A feasibility study
por: Van Malderen, Kathleen, et al.
Publicado: (2022)

Volatomics in inflammatory bowel disease and irritable bowel syndrome
por: Van Malderen, Kathleen, et al.
Publicado: (2020)

Main ion channels and receptors associated with visceral hypersensitivity in irritable bowel syndrome
por: de Carvalho Rocha, Heraldo Arcela, et al.
Publicado: (2014)

Proteolytic Cleavage of Bioactive Peptides and Protease-Activated Receptors in Acute and Post-Colitis
por: De bruyn, Michelle, et al.
Publicado: (2021)

New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome
por: Barshop, Kenneth, et al.
Publicado: (2016)

Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome
por: Asano, Teita, et al.
Publicado: (2017)

The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments
por: Farzaei, Mohammad H, et al.
Publicado: (2016)

Piezo2: A Candidate Biomarker for Visceral Hypersensitivity in Irritable Bowel Syndrome?
por: Bai, Tao, et al.
Publicado: (2017)

The Importance of Visceral Hypersensitivity in Irritable Bowel Syndrome—Plant Metabolites in IBS Treatment
por: Dudzińska, Ewa, et al.
Publicado: (2023)

Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis
por: Tian, Siyu, et al.
Publicado: (2023)

The efficacy and neural mechanism of acupuncture therapy in the treatment of visceral hypersensitivity in irritable bowel syndrome
por: Yang, Yuanzhen, et al.
Publicado: (2023)

Comparison of Electroacupuncture and Moxibustion for Relieving Visceral Hypersensitivity in Rats with Constipation-Predominant Irritable Bowel Syndrome
por: Zhao, Ji-Meng, et al.
Publicado: (2016)

Role of hippocampal circKcnk9 in visceral hypersensitivity and anxiety comorbidity of irritable bowel syndrome
por: Liu, Yuan, et al.
Publicado: (2022)

Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome
por: Zhang, Yu, et al.
Publicado: (2019)

Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms
por: Botschuijver, Sara, et al.
Publicado: (2019)

P2Y1R is involved in visceral hypersensitivity in rats with experimental irritable bowel syndrome
por: Wu, Jie, et al.
Publicado: (2017)

Comparison of the analgesic effects between electro-acupuncture and moxibustion with visceral hypersensitivity rats in irritable bowel syndrome
por: Zhao, Ji-Meng, et al.
Publicado: (2017)

Electroacupuncture Relieves Visceral Hypersensitivity by Inactivating Protease-Activated Receptor 2 in a Rat Model of Postinfectious Irritable Bowel Syndrome
por: Xu, Wanli, et al.
Publicado: (2018)

5-HT(7) receptor-dependent intestinal neurite outgrowth contributes to visceral hypersensitivity in irritable bowel syndrome
por: Chang, Wen-Ying, et al.
Publicado: (2022)

Effects of Massa Medicata Fermentata on the intestinal pathogenic flagella bacteria and visceral hypersensitivity in rats with irritable bowel syndrome
por: Zhuang, Zhaomeng, et al.
Publicado: (2022)

Gut Microbial β-Glucuronidases Regulate Host Luminal Proteases and are depleted in Irritable Bowel Syndrome
por: Edwinson, Adam L., et al.
Publicado: (2022)

Irritable bowel syndrome: Is it “irritable brain” or “irritable bowel”?
por: Padhy, Susanta Kumar, et al.
Publicado: (2015)

Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model
por: Chen, Bin-Rui, et al.
Publicado: (2017)

Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation
por: Zhou, Chunhua, et al.
Publicado: (2020)

P2X(3) Receptors Mediate Visceral Hypersensitivity during Acute Chemically-Induced Colitis and in the Post-Inflammatory Phase via Different Mechanisms of Sensitization
por: Deiteren, Annemie, et al.
Publicado: (2015)

A53 FECAL BIOACTIVE PHOSPHOLIPIDS AS TRIGGERS OF INTESTINAL HYPERSENSITIVITY IN IRRITABLE BOWEL SYNDROME
por: Pujo, J, et al.
Publicado: (2023)

What Is the Therapeutic Mechanism of the Probiotics in Irritable Bowel Syndrome Patients With Visceral Hypersensitivity?: (Neurogastroenterol Motil 2014;26:705–714)
por: Kim, Ji Won
Publicado: (2014)

PDIA3 gene induces visceral hypersensitivity in rats with irritable bowel syndrome through the dendritic cell-mediated activation of T cells
por: Zhuang, Zhaomeng, et al.
Publicado: (2016)

Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome
por: Zhu, Shi-Wei, et al.
Publicado: (2019)

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome
por: Zhang, Wen-Xue, et al.
Publicado: (2019)

Higher incidence of zinc and nickel hypersensitivity in patients with irritable bowel syndrome
por: Kageyama, Yasunari, et al.
Publicado: (2019)

Assessment of faecal microbial transfer in irritable bowel syndrome with severe bloating
por: Holvoet, Tom, et al.
Publicado: (2017)

Mast cell mediation of visceral sensation and permeability in irritable bowel syndrome
por: Hasler, William L., et al.
Publicado: (2022)

The endogenous hydrogen sulfide producing enzyme cystathionine-β synthase contributes to visceral hypersensitivity in a rat model of irritable bowel syndrome
por: Xu, Guang-Yin, et al.
Publicado: (2009)

Irritable bowel syndrome and diet
por: Portincasa, Piero, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2b5cjlkv9lcrlb31o88j3t2ofm